Rathbones Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Hold |
|
|||||
|
2025
Q1 | $85.3K | Hold |
|
|||||
|
2024
Q4 | $233K | Hold |
|
|||||
|
2024
Q3 | $411K | Hold |
|
|||||
|
2024
Q2 | $422K | Hold |
|
|||||
|
2024
Q1 | $684K | Hold |
|
|||||
|
2023
Q4 | $343K | Hold |
|
|||||
|
2023
Q3 | $338K | Hold |
|
|||||
|
2023
Q2 | $400K | Hold |
|
|||||
|
2023
Q1 | $472K | Hold |
|
|||||
|
2022
Q4 | $632K | Hold |
|
|||||
|
2022
Q3 | $465K | Hold |
|
|||||
|
2022
Q2 | $736K | Hold |
|
|||||
|
2022
Q1 | $892K | Hold |
|
|||||
|
2021
Q4 | $1.62M | Sell |
|
|||||
|
2021
Q3 | $2.24M | Hold |
|
|||||
|
2021
Q2 | $1.84M | Hold |
|
|||||
|
2021
Q1 | $2.3M | Hold |
|
|||||
|
2020
Q4 | $2.33M | Hold |
|
|||||
|
2020
Q3 | $3.46M | Sell |
|
|||||
|
2020
Q2 | $4.43M | Buy |
|
|||||
|
2020
Q1 | $1.08M | Sell |
|
|||||
|
2019
Q4 | $843K | Hold |
|
|||||
|
2019
Q3 | $1.06M | Sell |
|
|||||
|
2019
Q2 | $2.83M | Buy |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | $1.28M | Hold |
|
|||||
|
2018
Q3 | $3.03M | Sell |
|
|||||
|
2018
Q2 | $2.89M | Hold |
|
|||||
|
2018
Q1 | $2.73M | Sell |
|
|||||
|
2017
Q4 | $2.09M | Sell |
|
|||||
|
2017
Q3 | $2.63M | Buy |
|
|||||
|
2017
Q2 | $900K | Hold |
|
|||||
|
2017
Q1 | $1.1M | Hold |
|
|||||
|
2016
Q4 | $812K | Sell |
|
|||||
|
2016
Q3 | $2.33M | Sell |
|
|||||
|
2016
Q2 | $3.67M | Buy |
|
|||||
|
2016
Q1 | $1.63M | Hold |
|
|||||
|
2015
Q4 | $1.51M | Buy |
|